"Participant Blinding and Gastrointestinal Illness in a Randomized, Con" by John M. Colford, Judy R. Rees et al.
 

Document Type

Article

Journal Title

Emerging Infectious Diseases

Publication Date

2002

Volume

8

Abstract

We conducted a randomized, triple-blinded home drinking water intervention trial to determine if a large study could be undertaken while successfully blinding participants. Households were randomized 50:50 to use externally identical active or sham treatment devices. We measured the effectiveness of blinding of participants by using a published blinding index in which values >0.5 indicate successful blinding. The principal health outcome measured was "highly credible gastrointestinal illness" (HCGI). Participants (n=236) from 77 households were successfully blinded to their treatment assignment. At the end of the study, the blinding index was 0.64 (95% confidence interval 0.51-0.78). There were 103 episodes of HCGI during 10,790 person-days at risk in the sham group and 82 episodes during 11,380 person-days at risk in the active treatment group. The incidence rate ratio of disease (adjusted for the clustered sampling) was 1.32 (95% CI 0.75, 2.33) and the attributable risk was 0.24 (95% CI -0.33, 0.57). These data confirm that participants can be successfully blinded to treatment group assignment during a randomized trial of an in-home drinking water intervention.

ISSN

1080-6040

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Public Domain Dedication 1.0 License.

Rights

U.S. Government Work

Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 54
    • Policy Citations: 16
  • Usage
    • Downloads: 30
    • Abstract Views: 3
  • Captures
    • Readers: 67
see details

Included in

Epidemiology Commons

Share

COinS